News
Watch
Conferences
Publications
Events
CE
Resources
Subscribe

Spotlight -

Community/Retail|

Pharmacy Technician|

Michael Ruff, MD

Articles by Michael Ruff, MD

FGFR Inhibitors for Treatment of Primary CNS Tumors

BySydney E. Schultz, PharmD,Jason N. Barreto, PharmD,Carolyn Mead-Harvey, MS,Bryan Neth, MD, Samantha Caron, PA,Michael Ruff, MD,Joon Uhm MD,Susan Geyer PhD,Ugur Sener, MD

June 22nd 2026

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

Latest Updated Articles

FGFR Inhibitors for Treatment of Primary CNS Tumors
June 22nd 2026

Trending on Pharmacy Times

New Bladder Cancer Regimens Reshape Treatment Across Disease Stages

FDA Approves Levacetylleucine to Treat Ataxia in Adult, Pediatric Patients With A-T

Biologic Stewardship: The Next Frontier for Health System Pharmacists

Adult Respiratory Vaccination Delivers Up to $12 in Societal Value for Every $1 Spent, Analysis Finds

Baseline Interferon Activity in Monocytes Predicts mRNA Vaccine Adverse Effects, Study Finds